M&A Deal Summary |
|
|---|---|
| Date | 2013-05-21 |
| Target | AVANZA Laboratories |
| Sector | Life Science |
| Buyer(s) | Smithers Avanza |
| Sellers(s) | The BroadOak Fund |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Smithers Avanza is a contract research organization (CRO) supporting the pharmaceutical, agrochemical, and chemical industries.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2013) | 1 of 1 |
The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 6 |
| Sector (Life Science) | 1 of 5 |
| Type (Add-on Acquisition) | 1 of 5 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 1 of 6 |
| Year (2013) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-02-28 |
Aragen Bioscience
Morgan Hill, California, United States Aragen Bioscience, Inc. is a preclinical custom contract research organization that provides in vitro and in vivo research to pharmaceutical, biotechnology and research institutions. |
Sell | - |
